Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study

Therapeutic vaccines for non-Hodgkin B-cell lymphoma

Immunotherapy of hematological malignancies using dendritic cells

Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond

Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo

Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis

Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination

Comparison of dendritic cell-mediated immune responses among canine malignant cells

Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies

Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine